Doctors and medical organizations specializing in men's health have expressed skepticism regarding War Secretary Pete Hegseth's proposal to test all military service members for low testosterone levels. Hegseth's initiative aims to create a 'High-T' military force by screening service members over age 30 for low testosterone, which is important for various bodily functions including muscle growth and mood stabilization.
Testosterone levels naturally decline by about 1% each year after age 30, but significantly low levels can indicate hypogonadism, a condition defined by testosterone levels below 300 nanograms per deciliter. Experts recommend multiple blood tests to accurately assess testosterone levels, as they can vary daily.
Dr. Sevann Helo, a urology professor at the Mayo Clinic, noted that while screening could help identify early signs of hypogonadism, many cases are linked to other health issues such as obesity and diabetes. She emphasized the importance of a comprehensive approach to treatment, focusing on overall health rather than just hormone levels.
Stefan Pasiakos, a nutrition specialist at Louisiana State University, called for more clarity on the objectives of the screening policy. He expressed doubt that the proposed testing would reveal a significant number of low-T service members, suggesting that the prevalence would likely mirror that of the general population.
The Endocrine Society stated that diagnosing hypogonadism requires not only low testosterone levels but also physical symptoms. They cautioned against broad population-level screening for asymptomatic men.
Concerns regarding testosterone replacement therapy (TRT) include potential cardiovascular risks and effects on fertility, particularly for younger males. Dr. Helo highlighted the importance of counseling young men about the risks associated with TRT, including its potential to suppress sperm production.
Overall, medical professionals advocate for a careful and individualized approach to testosterone treatment, emphasizing the need to consider the patient's overall health and symptoms rather than solely relying on testosterone levels.